But there was more to this year than disease and strife. Big deals were done, innovations launched, and progress towards sustainability was made.
To read the roundup of the most important stories of the year, published in PKN's Nov-Dec 2020 issue, click here.
Elixinol Wellness has completed the sale of its US business and reported a narrowed first half loss, with revenue up 5.8 per cent to $7.2 million and gross margin close to 10 per cent higher as the group concentrates on its Australian food and wellness brands.
Nourish Ingredients has completed a 10-tonne industrial production run of its animal-free dairy fat, Creamilux, at SD Guthrie International’s facilities in the Netherlands, under a partnership that gives the Australian company European manufacturing capacity without building its own plant.
Bubs Australia has received permanent regulatory authorisation from the US FDA for its three infant formula products – Bubs Goat, Bubs 365 Day Grass Fed, and Bubs Essential.
